Sars-COV2 influenza multiplex
Ended Definitive Contract Awarded Last action
- Contract number
- 75D30123C16444
- Awardee
-
Biosearch Technologies, Inc. UEI NX7NLJUNSEU6
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $757,634
Award facts
- Opportunity
-
- GMP Manufacturing of CDC FluSC2 Multiplex EUA Kit Pre-Solicitation · 75D30123R72584 · Posted Feb 2, 2023
- Contract value 100% obligated
- $757,633.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Petaluma, CA, USA
- Legislative mandates
-
- Walsh-Healey Public Contracts Act FAR subpart 22.6
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$42,352 | |
| Additional Work (new agreement, FAR part 6 applies) | $399,993 | |
| Original award | $399,993 |
About this award
The Centers for Disease Control and Prevention awarded a $757,633.80 definitive contract to Biosearch Technologies, Inc. for manufacture of oligonucleotide primers and probes on April 26, 2023, on a sole-source basis.
The originating solicitation announced the CDC's intent to procure 1,020 vials of oligonucleotide primers and probes utilizing Good Manufacturing Practices for the FluSC2 Multiplex diagnostic test kits, which hold FDA Emergency Use Authorization. Biosearch Technologies is identified as the only approved source capable of providing materials with the specific internal quencher required to meet FDA regulatory standards. Place of performance is Petaluma, CA. The contract carries firm fixed price terms with an ultimate completion date of December 13, 2023. Work falls under NAICS 325414 and PSC R425.
Quick answers
Who was awarded contract 75D30123C16444?
75D30123C16444 was awarded to Biosearch Technologies, Inc. by CDC Pittsburgh (Centers for Disease Control and Prevention) on April 26, 2023.
How much is contract 75D30123C16444 worth?
The government has obligated $757,634 on 75D30123C16444.
Was contract 75D30123C16444 competed?
The extent of competition for 75D30123C16444 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award